Results 11 to 20 of about 14,252 (257)

Pulmonary delivery of liposomal dry powder inhaler formulation for effective treatment of idiopathic pulmonary fibrosis

Asian Journal of Pharmaceutical Sciences, 2018
Dry powder inhaler Liposomes were prepared to investigate the effectiveness of pulmonary delivery of Colchicine and Budesonide for Idiopathic Pulmonary fibrosis.
S. Chennakesavulu, A. Mishra, A. Sudheer, C. Sowmya, C. Suryaprakash Reddy, E. Bhargav   +5 more
doaj   +3 more sources

Fabrication and application of dimyristoyl phosphatidylcholine biomaterial-based nanocochleates dry powder inhaler for controlled release resveratrol delivery

Future Journal of Pharmaceutical Sciences, 2021
Background Resveratrol, a bioactive phytoconstituent, is used to treat chronic respiratory diseases. However, its clinical application was hampered due to its poor bioavailability.
A. J. Mali, P. A. Joshi, C. Bothiraja, A. P. Pawar   +3 more
doaj   +1 more source

Can Patients with Parkinson's Disease Use Dry Powder Inhalers during Off Periods? [PDF]

PLoS ONE, 2015
Because of its rapid onset of action, pulmonary administration of levodopa is an interesting alternative to oral administration for the rescue treatment of Parkinson's disease patients in an off period.
M Luinstra, A W F Rutgers, H Dijkstra, F Grasmeijer, P Hagedoorn, J M J Vogelzang, H W Frijlink, A H de Boer   +7 more
doaj   +1 more source

Inhaler Competence in Nepalese Patients with Asthma and Chronic Obstructive Pulmunory Disease: A Systematic Review

Journal of Nepal Health Research Council, 2022
Background: Incorrect use of inhalers in patients with asthma and chronic obstructive pulmonary disease is prevalent internationally. This review aims to determine the prevalence and associated factors of incorrect inhaler use and effectiveness of ...
Ramesh Sharma Poudel, Shakti Shrestha, Daniel Asfaw Erku, Praves Lamichhane, Sharad Karki, Dipesh Maskey, Shital Adhikari   +6 more
doaj   +1 more source

Novel Approaches for the Treatment of Pulmonary Tuberculosis

Pharmaceutics, 2020
Tuberculosis (TB) is a contagious airborne disease caused by Mycobacterium tuberculosis, which primarily affects human lungs. The progression of drug-susceptible TB to drug-resistant strains, MDR-TB and XDR-TB, has become worldwide challenge in ...
Zhi Ming Tan, Gui Ping Lai, Manisha Pandey, Teerapol Srichana, Mallikarjuna Rao Pichika, Bapi Gorain, Subrat Kumar Bhattamishra, Hira Choudhury   +7 more
doaj   +1 more source

Inhalable spray-dried chondroitin sulphate microparticles: effect of different solvents on particle properties and drug activity [PDF]

, 2020
Spray-drying stands as one of the most used techniques to produce inhalable microparticles, but several parameters from both the process and the used materials affect the properties of the resulting microparticles.
Buttini, Francesca, da Costa, Ana M Rosa, Faleiro, Maria Leonor, Flórez Fernández, Noelia, Grenha, Ana, Rodrigues, Susana, Torres, María Dolores   +6 more
core   +1 more source

Dry powder inhalation, part 1: ancient history and precursors to modern dry powder inhalers

Expert Opinion on Drug Delivery, 2022
Inhalation of herbs and other compounds has a long history but habits for medical treatment are intertwined with rituals to obtain hallucinatory effects and pleasurable sensations. Several examples of inhaled herbs, and the diseases they were used for, based on early translations of ancient manuscripts related to inhalation were found to be speculative
Anne Haaije de Boer, Paul Hagedoorn, Floris Grasmeijer   +2 more
openaire   +3 more sources

A Novel Curcumin-Based Drug Powder Inhalation Medicine for Chronic Obstructive Pulmonary Disease

Bioinorganic Chemistry and Applications, 2021
The dry powder inhaler is a new form of drug delivery that is widely used as an alternative to traditional drug delivery methods, addressing the shortcomings of traditional drug delivery methods and obtaining better therapeutic results.
Qin Shen, Yongjie Jiang, Jing Chen, Xueling Wang, Jiao Zheng   +4 more
doaj   +1 more source

Comparison of serious inhaler technique errors made by device-naïve patients using three different dry powder inhalers: a randomised, crossover, open-label study [PDF]

, 2016
Background: Serious inhaler technique errors can impair drug delivery to the lungs. This randomised, crossover, open-label study evaluated the proportion of patients making predefined serious errors with Pulmojet compared with Diskus and Turbohaler dry ...
A Palander, A Papi, Anne Burden, AS Melani, BL Laube, Catherine Hutton, D Price, D Price, D Price, D Price, David B. Price, Dawn Shan, E Mehuys, Erika Sims, F Lavorini, F Yildiz, Federico Lavorini, GK Crompton, GN Rootmensen, H Al-Jahdali, H Chrystyn, Henry Chrystyn, IA Basheti, J Haughney, J Haughney, J Palen van der, J Steier, JC McElnay, JC Virchow, JL Rau, John Efthimiou, John Haughney, KG Nielsen, L Borgstrom, M Molimard, M Molimard, M Moller, M Schulte, MA Crane, Mathieu Molimard, MS Blaiss, Nicolas Roche, PN Dekhuijzen, RA Al-Showair, S Verver, Sinthia Bosnic-Anticevich, SP Newman, SZ Bosnic-Anticevich, V Giraud, V Giraud, V Giraud, W Azouz, Y Aydemir   +52 more
core   +2 more sources

Dry powder inhalation: past, present and future [PDF]

Expert Opinion on Drug Delivery, 2016
Early dry powder inhalers (DPIs) were designed for low drug doses in asthma and COPD therapy. Nearly all concepts contained carrier-based formulations and lacked efficient dispersion principles. Therefore, particle engineering and powder processing are increasingly applied to achieve acceptable lung deposition with these poorly designed inhalers. Areas
De Boer, A. H, Hagedoorn, P, Hoppentocht, M, Grasmeijer, F, Frijlink, H. W., BUTTINI, Francesca   +5 more
openaire   +3 more sources